Chris van der Walle
PhD
Centre Director, Cell & Gene Therapy Catapult, Edinburgh
Â
After 14 years in academia I hopped over to the biopharmaceutical industry, first learning about the formulation of monoclonal antibodies in MedImmune before moving onto mRNA-lipid nanoparticles in AstraZeneca and then CAR-T cell processing and formulation at GlaxoSmithKline. I now lead the Cell & Gene Therapy Catapult’s new centre in Edinburgh, working on the scale-up, fill and finish of induced pluripotent stem cells. Along the way I have been lucky to meet both inspiring academics and industrial leaders, and studied some exciting science!